With the autumn awards circuit in full swing, Focus Features has put an end to a hard-fought bidding war among the major distributors and made it official: the studio holds the North American and certain international rights to Elsinore. The Simon Stone biographical drama was much in demand after early showings for the industry.
To mark the occasion, the studio has set a limited theatrical debut for November 20, 2026, with plans to broaden the release come Thanksgiving and into December. But first, Elsinore will have its moment in the spotlight at some of the top festivals, most notably in the Special Presentations lineup at this year’s Toronto International Film Festival.
A Triumph of Spirit and Mortality
At the heart of the film is the true story of Ian Charleson, the celebrated Scottish actor, as told by BAFTA laureate Stephen Beresford (Pride). In 1989, at the peak of his abilities, Charleson was set to deliver the Hamlet of a lifetime at London’s National Theatre. Yet he was doing so while contending with the ravages of AIDS. What followed was a final performance of rare grace and defiance, one that was as artistically brilliant as it was moving.
Andrew Scott takes on the role of Charleson in what is being touted as a career-making turn. He is supported by a fine cast, including Billie Piper, Johnny Flynn, Luke Thompson, Monica Dolan, Juliet Stevenson, Joe Locke and David Dawson. Olivia Colman, the Academy Award winner, is on hand to play the actor’s doctor.
A Coup for Focus Features
For Focus Features, the acquisition of Elsinore is no small matter. The studio has made of it a linchpin in its awards strategy for the latter part of the year. An effort from producers at STUDIOCANAL, LD Entertainment, Lucky Red and Magnolia Mae Films, the film is an amalgam of West End’s electric theatre culture and the kind of intimate tragedy one finds in real history.
Then there is the direction of Simon Stone. Having put his particular gift for emotional gravity on show with The Dig, he brings to the helm all the credentials of a project meant to be a heavyweight on the fall festival circuit. When Scott takes on one of the stage’s most famous modern-day testaments, one can expect Elsinore to rank among the more moving cinematic offerings of the year.
It is easy to expect a biopic of a theatrical luminary to lapse into some form of hagiography. Not so with Elsinore. In zeroing in on the unvarnished courage of Ian Charleson as he approaches his last curtain call, the film sidesteps the usual genre conventions. With Andrew Scott’s forceful presence and the full weight of Focus Features behind it, the movie is set to be an emotional heavyweight this autumn.